Literature DB >> 2868753

A blind randomised cross-over trial comparing metipranolol 0.3% with timolol 0.25% in open-angle glaucoma: a pilot study.

K B Mills, G Wright.   

Abstract

A blind randomised cross-over study was conducted on 10 patients (20 eyes) to compare the effect in patients with open-angle glaucoma of metipranolol 0.3% with that of timolol 0.25% on intraocular pressure following one month's topical instillation with each preparation alone. There was no statistically significant difference in intraocular pressure reduction between these two preparations, and the ocular tolerance of both was good. There was no significant difference in the blood pressure, pulse, or pupil diameters of patients receiving either preparation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2868753      PMCID: PMC1040901          DOI: 10.1136/bjo.70.1.39

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  5 in total

1.  Trimolol: effect on intraocular pressure in chronic open-angle glaucoma.

Authors:  S A Obstbaum; M A Galin; I M Katz
Journal:  Ann Ophthalmol       Date:  1978-10

2.  Intraocular pressure decrease in normal volunteers following timolol ophthalmic solution.

Authors:  I M Katz; W A Hubbard; A J Getson; A L Gould
Journal:  Invest Ophthalmol       Date:  1976-06

3.  Timolol maleate, a new beta-adrenergic receptor blocking agent.

Authors:  R A Hall; R D Robson; N N Share
Journal:  Arch Int Pharmacodyn Ther       Date:  1975-02

4.  Timolol. A beta-adrenergic blocking agent for the treatment of glaucoma.

Authors:  T J Zimmerman; H E Kaufman
Journal:  Arch Ophthalmol       Date:  1977-04

5.  Timolol. A new drug for management of chronic simple glaucoma.

Authors:  R L Radius; G R Diamond; I P Pollack; M E Langham
Journal:  Arch Ophthalmol       Date:  1978-06
  5 in total
  6 in total

Review 1.  Ocular metipranolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in glaucoma and ocular hypertension.

Authors:  P E Battershill; E M Sorkin
Journal:  Drugs       Date:  1988-11       Impact factor: 9.546

2.  Ocular and cardiovascular response to topical carteolol 2% and timolol 0.5% in healthy volunteers.

Authors:  D J Brazier; S E Smith
Journal:  Br J Ophthalmol       Date:  1988-02       Impact factor: 4.638

3.  Metipranolol-associated granulomatous anterior uveitis.

Authors:  T Akingbehin; J R Villada
Journal:  Br J Ophthalmol       Date:  1991-09       Impact factor: 4.638

4.  Cardiovascular responses to metipranolol and timolol eyedrops in healthy volunteers.

Authors:  P J Bacon; D J Brazier; R Smith; S E Smith
Journal:  Br J Clin Pharmacol       Date:  1989-01       Impact factor: 4.335

Review 5.  Ocular beta-blockers in glaucoma management. Clinical pharmacological aspects.

Authors:  A M Brooks; W E Gillies
Journal:  Drugs Aging       Date:  1992 May-Jun       Impact factor: 3.923

6.  Levobunolol and metipranolol: comparative ocular hypotensive efficacy, safety, and comfort.

Authors:  G K Krieglstein; G D Novack; E Voepel; G Schwarzbach; U Lange; K P Schunck; J C Lue; E P Glavinos
Journal:  Br J Ophthalmol       Date:  1987-04       Impact factor: 4.638

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.